#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Human papilloma virus immunisation Cardiac sarcoidosis Kaposi's sarcoma Still's disease Lupus nephritis Antiphospholipid antibodies Lennox-Gastaut syndrome Diabetes insipidus Andersen-Tawil syndrome Hairy cell leukaemia B-cell small lymphocytic lymphoma Aicardi-Goutieres syndrome Microvillous inclusion disease Insulinoma Glomerulonephritis acute More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Basic Information Marfan’s syndrome – Diagnostics Adrenocortical carcinoma – Diagnostics Cytokine release syndrome – Basic Information Angiosarcoma recurrent – Treatment IgA nephropathy – Trials in Disease Krabbe’s disease – Diagnostics Gaucher’s disease type III – Diagnostics Mantle cell lymphoma refractory – Life with Disease Glycogen storage disease type V – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Etifoxine Hydrochloride Paclitaxel Obaluronate Luspatercept Doxazosin Mesilate L-Glutamic Acid Dotatate Ptg-Carcik-Cd19 Leniolisib Phosphate Levobupivacaine Hydrochloride Medroxyprogesterone Acetate Adapalene 177Lu-Rhpsma-10.1 Colistimethate Sodium Tretinoin Levonorgestrel Minoxidil Inebilizumab MALIC ACID Doxycycline Monohydrate Sodium Gluconate More therapies…

    Learn about Your Condition

    Hepatic fibrosis Acute hepatic failure Intermittent claudication Intestinal ischaemia Senile dementia Short stature Ischaemic skin ulcer Pneumonia bacterial Persistent depressive disorder Tendon disorder Peritonitis Ankylosing spondylitis Macular degeneration Dementia Epicondylitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Dinutuximab Beta and Drug Combination for Children, Teens, and Adults with GD2-Positive Ewing Sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Mesna
    • Filgrastim
    Austria Czechia Germany Sweden

  • Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Fludarabine Phosphate
    • Cyclophosphamide
    France Germany Italy Spain

  • Study on Preventing Heart Transplant Rejection in Children Using Autologous Treg Cells (thyTreg)

    Recruiting

    1 1 1
    Investigated Diseases:
    • Heart transplant
    Spain

  • Study Comparing Gallium (68Ga) Gozetotide and Zirconium (89Zr) Girentuximab PET Scans for Detecting Tumors in Patients with Metastatic Renal Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Gallium (68Ga) Gozetotide
    • ZIRCONIUM (89ZR) GIRENTUXIMAB
    • Gozetotide
    The Netherlands

  • Study on the Safety of Anti-GD2 CAR T Cells, Cyclophosphamide, and Fludarabine in Children and Young Adults with Relapsed or Refractory Brain Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant central nervous system neoplasm
    Investigated Drugs:
    • AUTOLOGOUS T CELLS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING A CHIMERIC ANTIGEN RECEPTOR AGAINST GD2, EX-VIVO EXPANDED
    • RIMIDUCID
    • Fludarabine Phosphate
    Italy

  • Study of iG-Tregs for Preventing Graft-versus-Host Disease in Adults Undergoing HLA-Matched Sibling Stem Cell Transplantation

    Recruiting

    1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • IG-TREGS
    Greece
Previous Page
1 … 240 241 242 243 244 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!